A new extranodal scoring system based on the prognostically relevant extranodal sites in diffuse large B-cell lymphoma, not otherwise specified treated with chemoimmunotherapy

Secondary Cutaneous Diffuse Large B-cell Lymphoma has a Higher International Prognostic Index Score and Worse Prognosis Than Diffuse Large B-cell Lymphoma, Leg Type

(2016) W Lee et al.   ACTA DERMATO-VENEREOLOGICA

Body mass index as a prognostic factor in Asian patients treated with chemoimmunotherapy for diffuse large B cell lymphoma, not otherwise specified

(2015) Hee Sang Hwang et al.   ANNALS OF HEMATOLOGY

Diffuse large B-cell lymphoma: sites of extranodal involvement are a stronger prognostic indicator than number of extranodal sites in the rituximab era

(2015) Chieh-Sheng Lu et al.   LEUKEMIA & LYMPHOMA

Evaluating Random Forests for Survival Analysis Using Prediction Error Curves

(2015) Ulla B. Mogensen et al.   Journal of Statistical Software

Intestinal Diffuse Large B-Cell Lymphoma: An Evaluation of Different Staging Systems

(2014) Hee Sang Hwang et al.   JOURNAL OF KOREAN MEDICAL SCIENCE

An enhanced International Prognostic Index (NCCN-IPI) for patients with diffuse large B-cell lymphoma treated in the rituximab era

(2013) Z. Zhou et al.   BLOOD

Phenotype profiling of primary testicular diffuse large B-cell lymphomas

(2013) Thomas Menter et al.   HEMATOLOGICAL ONCOLOGY

Risk prediction models: I. Development, internal validation, and assessing the incremental value of a new (bio)marker

(2012) Karel G M Moons et al.   HEART

Prognostic factors in primary diffuse large B-cell lymphoma of adrenal gland treated with rituximab-CHOP chemotherapy from the Consortium for Improving Survival of Lymphoma (CISL)

(2012) Yu Kim et al.   Journal of Hematology & Oncology

Prognostic impact of extranodal involvement in diffuse large B-cell lymphoma in the rituximab era

(2011) Hiroyuki Takahashi et al.   CANCER

Diffuse large B-cell lymphoma with involvement of the kidney: outcome and risk of central nervous system relapse

(2011) D. Villa et al.   HAEMATOLOGICA

Comparison of treatment strategies for patients with intestinal diffuse large B-cell lymphoma: surgical resection followed by chemotherapy versus chemotherapy alone

(2010) S. J. Kim et al.   BLOOD

Prognostic implications of extranodal involvement in patients with diffuse large B-cell lymphoma treated with rituximab and cyclophosphamide, doxorubicin, vincristine, and prednisone

(2010) David Hui et al.   LEUKEMIA & LYMPHOMA

Most primary adrenal lymphomas are diffuse large B-cell lymphomas with non-germinal center B-cell phenotype, BCL6 gene rearrangement and poor prognosis

(2009) Ana Mozos et al.   MODERN PATHOLOGY